Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.
J Clin Invest. 2023 Sep 1;133(17):e164258. doi: 10.1172/JCI164258.
J Clin Invest. 2023.
PMID: 37655661
Free PMC article.
Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors.
Brightman SE, Becker A, Thota RR, Naradikian MS, Chihab L, Zavala KS, Ramamoorthy Premlal AL, Griswold RQ, Dolina JS, Cohen EEW, Miller AM, Peters B, Schoenberger SP.
Brightman SE, et al. Among authors: ramamoorthy premlal al.
Nat Immunol. 2023 Aug;24(8):1391. doi: 10.1038/s41590-023-01591-1.
Nat Immunol. 2023.
PMID: 37464051
Free PMC article.
No abstract available.
Item in Clipboard
Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors.
Brightman SE, Becker A, Thota RR, Naradikian MS, Chihab L, Zavala KS, Ramamoorthy Premlal AL, Griswold RQ, Dolina JS, Cohen EEW, Miller AM, Peters B, Schoenberger SP.
Brightman SE, et al. Among authors: ramamoorthy premlal al.
Nat Immunol. 2023 Aug;24(8):1345-1357. doi: 10.1038/s41590-023-01543-9. Epub 2023 Jul 3.
Nat Immunol. 2023.
PMID: 37400675
Free PMC article.
Item in Clipboard
Cite
Cite